Mihara M - Search Results

1

Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.

Wang X, Huang W, Schiffer LE, Mihara M, Akkerman A, Hiromatsu K, Davidson A. Wang X, et al. Among authors: mihara m. Arthritis Rheum. 2003 Feb;48(2):495-506. doi: 10.1002/art.10929. Arthritis Rheum. 2003. PMID: 12571860 Free article.

2

Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus erythematosus.

Wang X, Huang W, Mihara M, Sinha J, Davidson A. Wang X, et al. Among authors: mihara m. J Immunol. 2002 Feb 15;168(4):2046-53. doi: 10.4049/jimmunol.168.4.2046. J Immunol. 2002. PMID: 11823542

3

Co-stimulatory blockade in the treatment of murine systemic lupus erythematosus (SLE).

Davidson A, Wang X, Mihara M, Ramanujam M, Huang W, Schiffer L, Sinha J. Davidson A, et al. Among authors: mihara m. Ann N Y Acad Sci. 2003 Apr;987:188-98. doi: 10.1111/j.1749-6632.2003.tb06048.x. Ann N Y Acad Sci. 2003. PMID: 12727639 Review.

4

CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus.

Mihara M, Tan I, Chuzhin Y, Reddy B, Budhai L, Holzer A, Gu Y, Davidson A. Mihara M, et al. J Clin Invest. 2000 Jul;106(1):91-101. doi: 10.1172/JCI9244. J Clin Invest. 2000. PMID: 10880052 Free PMC article.

5

Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.

Takagi N, Mihara M, Moriya Y, Nishimoto N, Yoshizaki K, Kishimoto T, Takeda Y, Ohsugi Y. Takagi N, et al. Among authors: mihara m. Arthritis Rheum. 1998 Dec;41(12):2117-21. doi: 10.1002/1529-0131(199812)41:12<2117::AID-ART6>3.0.CO;2-P. Arthritis Rheum. 1998. PMID: 9870868

6

Preventive effect of a novel antifolate, MX-68, in murine systemic lupus erythematosus (SLE).

Mihara M, Takagi N, Urakawa K, Moriya Y, Takeda Y. Mihara M, et al. Int J Immunopharmacol. 1997 Feb;19(2):67-74. doi: 10.1016/s0192-0561(97)00015-5. Int J Immunopharmacol. 1997. PMID: 9278176

7

Murine tumor necrosis factor α-induced adipose-related protein (tumor necrosis factor α-induced protein 9) deficiency leads to arthritis via interleukin-6 overproduction with enhanced NF-κB, STAT-3 signaling, and dysregulated apoptosis of macrophages.

Inoue A, Matsumoto I, Tanaka Y, Umeda N, Tanaka Y, Mihara M, Takahashi S, Sumida T. Inoue A, et al. Among authors: mihara m. Arthritis Rheum. 2012 Dec;64(12):3877-85. doi: 10.1002/art.34666. Arthritis Rheum. 2012. PMID: 22886597 Free article.

8

Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.

Iwanami K, Matsumoto I, Tanaka-Watanabe Y, Inoue A, Mihara M, Ohsugi Y, Mamura M, Goto D, Ito S, Tsutsumi A, Kishimoto T, Sumida T. Iwanami K, et al. Among authors: mihara m. Arthritis Rheum. 2008 Mar;58(3):754-63. doi: 10.1002/art.23222. Arthritis Rheum. 2008. PMID: 18311788 Free article.

9

Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.

Fujimoto M, Serada S, Mihara M, Uchiyama Y, Yoshida H, Koike N, Ohsugi Y, Nishikawa T, Ripley B, Kimura A, Kishimoto T, Naka T. Fujimoto M, et al. Among authors: mihara m. Arthritis Rheum. 2008 Dec;58(12):3710-9. doi: 10.1002/art.24126. Arthritis Rheum. 2008. PMID: 19035481 Free article.

10

Effect of methotrexate treatment on the onset of autoimmune kidney disease in lupus mice.

Mihara M, Katsume A, Takeda Y. Mihara M, et al. Chem Pharm Bull (Tokyo). 1992 Aug;40(8):2177-81. doi: 10.1248/cpb.40.2177. Chem Pharm Bull (Tokyo). 1992. PMID: 1423777

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

647 results

Search Page

Filters